Challenges of STEMI care in India & the real world.
作者信息
Chopra H K
机构信息
Senior Consultant Cardiologist, Moolchand Medcity, New Delhi, India.
出版信息
Indian Heart J. 2015 Jan-Feb;67(1):15-7. doi: 10.1016/j.ihj.2015.02.011. Epub 2015 Mar 14.
Abstract
摘要
相似文献
1
Challenges of STEMI care in India & the real world.印度及现实世界中ST段抬高型心肌梗死治疗面临的挑战。
Indian Heart J. 2015 Jan-Feb;67(1):15-7. doi: 10.1016/j.ihj.2015.02.011. Epub 2015 Mar 14.
2
Pharmacoinvasive Approach with Streptokinase in Low to Intermediate Risk ST-Elevation Myocardial Infarction Patients: Insights from the Tamil Nadu-STEMI Initiative.
Am J Cardiovasc Drugs. 2019 Oct;19(5):517-519. doi: 10.1007/s40256-019-00327-7.
3
Thrombolysis-Guided Primary Percutaneous Coronary Intervention.溶栓引导的直接经皮冠状动脉介入治疗
J Invasive Cardiol. 2018 Dec;30(12):E154.
4
Pharmacoinvasive and Primary Percutaneous Coronary Intervention Strategies in ST-Elevation Myocardial Infarction (from the Mayo Clinic STEMI Network).ST段抬高型心肌梗死的药物侵入性与直接经皮冠状动脉介入治疗策略（来自梅奥诊所ST段抬高型心肌梗死网络）
Am J Cardiol. 2016 Jun 15;117(12):1904-10. doi: 10.1016/j.amjcard.2016.03.036. Epub 2016 Apr 6.
5
[Preclinical fibrinolysis in patients with ST-segment elevation myocardial infarction in a rural region].[农村地区ST段抬高型心肌梗死患者的临床前纤维蛋白溶解]
Anaesthesist. 2016 Sep;65(9):673-80. doi: 10.1007/s00101-016-0206-z. Epub 2016 Aug 8.
6
The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme.护理系统对链激酶药物侵入性管理的影响：TN-STEMI项目的亚组分析。
Indian Heart J. 2017 Sep-Oct;69(5):573-579. doi: 10.1016/j.ihj.2017.07.006. Epub 2017 Jul 18.
7
Comparative effectiveness of primary PCI versus fibrinolytic therapy for ST elevation myocardial infarction: a review of the literature.直接经皮冠状动脉介入治疗与溶栓治疗急性 ST 段抬高型心肌梗死的疗效比较：文献复习。
J Comp Eff Res. 2016 Mar;5(2):217-26. doi: 10.2217/cer-2015-0011. Epub 2016 Mar 7.
8
Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.新冠病毒 19 型合并 ST 段抬高型心肌梗死患者的直接经皮冠状动脉介入治疗或溶栓治疗
Am J Cardiol. 2020 Nov 1;134:158. doi: 10.1016/j.amjcard.2020.08.021. Epub 2020 Aug 22.
9
Reduction Of St Segment Elevation In Diabetic Patients With Myocardial Infarction After Thrombolytic Therapy.溶栓治疗后糖尿病心肌梗死患者ST段抬高的降低
J Ayub Med Coll Abbottabad. 2017 Apr-Jun;29(2):308-310.
10
STEMI vs NSTEACS management trends in non-invasive hospital.非侵入性医院中ST段抬高型心肌梗死与非ST段抬高型急性冠脉综合征的管理趋势
Indian Heart J. 2016 Jul-Aug;68(4):519-22. doi: 10.1016/j.ihj.2015.11.006. Epub 2016 Jan 12.
引用本文的文献
1
Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India.印度心脏病学会：印度ST段抬高型心肌梗死管理的立场声明。
Indian Heart J. 2017 Apr;69 Suppl 1(Suppl 1):S63-S97. doi: 10.1016/j.ihj.2017.03.006. Epub 2017 Mar 23.
本文引用的文献
1
2
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.ST 段抬高型心肌梗死患者随机分为药物介入策略组或直接经皮冠状动脉介入治疗组：心肌梗死后早期再灌注策略（STREAM）1 年死亡率随访。
Circulation. 2014 Sep 30;130(14):1139-45. doi: 10.1161/CIRCULATIONAHA.114.009570. Epub 2014 Aug 26.
3
Pharmacologic reperfusion therapy with indigenous tenecteplase in 15,222 patients with ST elevation myocardial infarction - the Indian Registry.印度注册研究：15222例ST段抬高型心肌梗死患者使用国产替奈普酶进行药物再灌注治疗
Indian Heart J. 2013 Jul-Aug;65(4):436-41. doi: 10.1016/j.ihj.2013.06.010. Epub 2013 Jul 10.
4
Review of tenecteplase (TNKase) in the treatment of acute myocardial infarction.替奈普酶（TNKase）治疗急性心肌梗死的综述。
Vasc Health Risk Manag. 2009;5(1):249-56. doi: 10.2147/vhrm.s3848. Epub 2009 Apr 8.
5
Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).抗栓与溶栓治疗：美国胸科医师学会循证临床实践指南（第8版）
Chest. 2008 Jun;133(6 Suppl):110S-112S. doi: 10.1378/chest.08-0652.
6
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data.印度急性冠状动脉综合征的治疗与转归（CREATE）：一项登记数据的前瞻性分析
Lancet. 2008 Apr 26;371(9622):1435-42. doi: 10.1016/S0140-6736(08)60623-6.
7
Predictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) database.ST段抬高型心肌梗死患者住院死亡率的预测因素：一项使用心肌梗死国家审计项目（MINAP）数据库的真实世界研究。
Heart. 2008 Nov;94(11):1407-12. doi: 10.1136/hrt.2007.127068. Epub 2007 Dec 10.
8
The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.法国急性ST段抬高或非ST段抬高型心肌梗死注册研究（FAST-MI）：研究设计与基线特征
Arch Mal Coeur Vaiss. 2007 Jun-Jul;100(6-7):524-34.
9
Regional systems of care to optimize timeliness of reperfusion therapy for ST-elevation myocardial infarction: the Mayo Clinic STEMI Protocol.优化ST段抬高型心肌梗死再灌注治疗及时性的区域护理系统：梅奥诊所ST段抬高型心肌梗死治疗方案
Circulation. 2007 Aug 14;116(7):729-36. doi: 10.1161/CIRCULATIONAHA.107.699934. Epub 2007 Aug 1.
10
Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events.接受纤维蛋白溶解和直接经皮冠状动脉介入治疗的患者治疗延迟与死亡率的关系。全球急性冠状动脉事件注册研究。
Heart. 2007 Dec;93(12):1552-5. doi: 10.1136/hrt.2006.112847. Epub 2007 Jun 25.
Zotero 插件